피펫은 테스트 튜브에 삽입

RT-PCR

Detection Kits 

Molecular Diagnosis

WHO currently recommends a single approach to clinical diagnostic testing for disease confirmation which is the detection of unique sequences of SARS-CoV-2 RNA by nucleic acid amplification testing (NAAT), such as real-time reverse-transcription polymerase chain reaction (rRT-PCR).

Sol paper.png

[Letter of Priority Distributorship Authorization]

SolGent

DiaPlexQ™

Novel Coronavirus (2019-nCoV) Detection Kit

FDA-EUA Approved

  • DiaPlexQ™ Novel Coronavirus(2019-nCov) Detection Kit is a CE-IVD assay reagent.

  • It is designed to detect the nucleic acid of novel coronavirus contained in total RNA extracted from blood suspected patients.

  • The kit is based on Real-Time RT PCR method.

  • Additional reagent purchase is not needed, as 5 components are equipped required for PCR reaction.

  • SolGent's OneStep qRT-PCR method performs RT reaction and Real-time PCR amplification reaction sequentially in one tube without separate experiment for RT reaction.

  • Detection time, cost and sensitivity were improved compared to conventional PCR diagnosis.

AcheQ.png

AMSBIO

A+CheQ

COVID-19 High Speed RT-qPCR

KFDA-EUA Approved

  • Fastest COVID-19 Detection Kit  (Within 1 hour from specimen extraction to diagnosis results)

  • 100% Accuracy diagnosis (Sensitivity: 100% / Specificity: 100)

  • High compatibility with various Real-time PCR equipments

  • Establishment of the largest production facility in Korea (Minimum 2,000 kits can be produced per day)  

  • Cat. No. : RR001

  • 100 Tests/Kit

  • Storage : − 24°C ~ − 18°C

  • Sample to Result : 52 min [Prep 23 min + qPCR 29 min] 3-plex Multiplex

  • Clinical Sensitivity : 100%

  • Clinical Specificity : 100%

Direct Contact Info

*For any inquiries
please contact the following E-mail address

Jason Cho 

jason@caremile.co.kr